Cargando…
Kampo medicines improved blood test and QOL in two vasculitis cases of Churg–Strauss syndrome and Henoch–Shönlein purpura after inadequate treatment with conventional therapies
OBJECTIVE: Based on the tenets of traditional Chinese medicine (TCM) theory, Kampo medicines were selected and applied to two cases of Churg–Strauss syndrome and Henoch–Shönlein purpura. Two vasculitis syndrome patients exhibited persistent symptoms and abnormal blood tests after treatment with conv...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866557/ https://www.ncbi.nlm.nih.gov/pubmed/20463826 |
_version_ | 1782180928522551296 |
---|---|
author | Hijikata, Yasuyo Ikemoto, Yumiko Kohdera, Urara |
author_facet | Hijikata, Yasuyo Ikemoto, Yumiko Kohdera, Urara |
author_sort | Hijikata, Yasuyo |
collection | PubMed |
description | OBJECTIVE: Based on the tenets of traditional Chinese medicine (TCM) theory, Kampo medicines were selected and applied to two cases of Churg–Strauss syndrome and Henoch–Shönlein purpura. Two vasculitis syndrome patients exhibited persistent symptoms and abnormal blood tests after treatment with conventional therapies. METHODS: As the two cases had “blood stagnation” and “damps and heat” and one had a “yang deficiency” in terms of TCM theory, we applied certain selected Kampo medicines. RESULTS: In case 1, the patient presented with hypereosinophilia, venous thrombosis, pulmonary infarction, decreased platelet count, ulner nerve palsy and Raynaud’s phenomena, which led to a diminished quality of life. After starting the Kampo medicines, the patient improved quickly and recovered within 11 months. In case 2, persistent purpura, abdominal pain, and bloody feces quickly improved and disappeared after Kampo treatment. After starting the Kampo medicines, prednisolone was stopped at 21 days without any sign of relapse to date. CONCLUSION: Kampo medicines helped clear the persistent abnormal symptoms and laboratory findings of vasculitis syndromes, Churg–Strauss syndrome and Henoch–Shönlein purpura, which had responded inadequately to the conventional therapies administered. |
format | Text |
id | pubmed-2866557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-28665572010-05-12 Kampo medicines improved blood test and QOL in two vasculitis cases of Churg–Strauss syndrome and Henoch–Shönlein purpura after inadequate treatment with conventional therapies Hijikata, Yasuyo Ikemoto, Yumiko Kohdera, Urara Int J Gen Med Short Report OBJECTIVE: Based on the tenets of traditional Chinese medicine (TCM) theory, Kampo medicines were selected and applied to two cases of Churg–Strauss syndrome and Henoch–Shönlein purpura. Two vasculitis syndrome patients exhibited persistent symptoms and abnormal blood tests after treatment with conventional therapies. METHODS: As the two cases had “blood stagnation” and “damps and heat” and one had a “yang deficiency” in terms of TCM theory, we applied certain selected Kampo medicines. RESULTS: In case 1, the patient presented with hypereosinophilia, venous thrombosis, pulmonary infarction, decreased platelet count, ulner nerve palsy and Raynaud’s phenomena, which led to a diminished quality of life. After starting the Kampo medicines, the patient improved quickly and recovered within 11 months. In case 2, persistent purpura, abdominal pain, and bloody feces quickly improved and disappeared after Kampo treatment. After starting the Kampo medicines, prednisolone was stopped at 21 days without any sign of relapse to date. CONCLUSION: Kampo medicines helped clear the persistent abnormal symptoms and laboratory findings of vasculitis syndromes, Churg–Strauss syndrome and Henoch–Shönlein purpura, which had responded inadequately to the conventional therapies administered. Dove Medical Press 2010-04-08 /pmc/articles/PMC2866557/ /pubmed/20463826 Text en © 2010 Hijikata et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Short Report Hijikata, Yasuyo Ikemoto, Yumiko Kohdera, Urara Kampo medicines improved blood test and QOL in two vasculitis cases of Churg–Strauss syndrome and Henoch–Shönlein purpura after inadequate treatment with conventional therapies |
title | Kampo medicines improved blood test and QOL in two vasculitis cases of Churg–Strauss syndrome and Henoch–Shönlein purpura after inadequate treatment with conventional therapies |
title_full | Kampo medicines improved blood test and QOL in two vasculitis cases of Churg–Strauss syndrome and Henoch–Shönlein purpura after inadequate treatment with conventional therapies |
title_fullStr | Kampo medicines improved blood test and QOL in two vasculitis cases of Churg–Strauss syndrome and Henoch–Shönlein purpura after inadequate treatment with conventional therapies |
title_full_unstemmed | Kampo medicines improved blood test and QOL in two vasculitis cases of Churg–Strauss syndrome and Henoch–Shönlein purpura after inadequate treatment with conventional therapies |
title_short | Kampo medicines improved blood test and QOL in two vasculitis cases of Churg–Strauss syndrome and Henoch–Shönlein purpura after inadequate treatment with conventional therapies |
title_sort | kampo medicines improved blood test and qol in two vasculitis cases of churg–strauss syndrome and henoch–shönlein purpura after inadequate treatment with conventional therapies |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866557/ https://www.ncbi.nlm.nih.gov/pubmed/20463826 |
work_keys_str_mv | AT hijikatayasuyo kampomedicinesimprovedbloodtestandqolintwovasculitiscasesofchurgstrausssyndromeandhenochshonleinpurpuraafterinadequatetreatmentwithconventionaltherapies AT ikemotoyumiko kampomedicinesimprovedbloodtestandqolintwovasculitiscasesofchurgstrausssyndromeandhenochshonleinpurpuraafterinadequatetreatmentwithconventionaltherapies AT kohderaurara kampomedicinesimprovedbloodtestandqolintwovasculitiscasesofchurgstrausssyndromeandhenochshonleinpurpuraafterinadequatetreatmentwithconventionaltherapies |